Publications by authors named "J Armentia Perez de Mendiola"
Article Synopsis
- - The study focuses on creating new hydrophobic solvents to replace the toxic hexane in extracting fatty acids and bioactive compounds from almond and peanut coproducts, emphasizing sustainable processing methods.
- - Four solvent mixtures were developed using terpene components, and while melting point analyses revealed inconsistencies with COSMO-RS predictions, they exhibited low viscosity, enhancing extraction efficiency.
- - The new solvents achieved similar extraction yields to hexane, with specific mixtures outperforming hexane in extracting certain components, making them suitable for food and pharmaceutical applications.
Thrombosis in breast cancer patients on cyclin-dependent kinase inhibitors: Survival impact and predictive factors - A study by the cancer and thrombosis group of the spanish society of medical oncology (SEOM).
Eur J Intern Med
December 2024
Thrombosis may be included in the profile of side effects associated with CDK4/6 inhibitors. Its significance might be greater than reported in randomized clinical trials. To investigate this, a retrospective, multicenter study was conducted.
View Article and Find Full Text PDFArticle Synopsis
- * The study determined PCOS diagnoses based on Rotterdam criteria and used a food frequency questionnaire to assess coffee intake, categorizing it as none, less than one cup, one cup, or two or more cups per day.
- * Findings indicated that higher coffee intake was associated with a lower likelihood of having PCOS; women with PCOS were significantly less likely to drink one cup of coffee daily compared to non-drinkers, suggesting coffee may help alleviate PC
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.
Clin Transl Oncol
June 2024
Purpose: Both venous and arterial thrombotic events (VTE/AT) can be associated with Immune Checkpoint Inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice.
Methods: /Patients.
Background: Greater trochanteric pain syndrome (GTPS) is characterized by gluteal enthesopathy involving the peritrochanteric space and associated with chronic pain and functional impairment. A corticosteroid injection in the trochanteric bursa is the usual palliative treatment for pain. However, it is important to investigate treatment options that will relieve pain in the peritrochanteric space.
View Article and Find Full Text PDF